Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87481048 |
Registration Number | 6309200 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Gregory B. Coy |
Attorney Docket Number | HYC03-129 |
Law Office Assigned | M60 |
Employee Name | FRENCH, CURTIS W |
2017-06-08 | Application Filed |
2017-12-12 | Published for Opposition |
2018-02-06 | Location: INTENT TO USE SECTION |
2019-02-05 | Status: Live/Pending |
2019-02-06 | Transaction Date |
2021-03-30 | Trademark Registered |
Owner: | ![]() |
Address | 7272 Chapman Avenue Garden Grove DE 92841 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 37 |
U.S. Codes: | 100,103,106 |
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Diagnostic reagents and preparations for scientific, clinical laboratory, medical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research use; control and calibrating fluids and reagents for medical diagnostic instruments; control and calibrating fluids and reagents for laboratory instruments used for in vitro diagnostic testing and/or analysis; diagnostic reagents for scientific or medical research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; reagents for use in scientific apparatus for chemical or biological analysis; laboratory chemicals, namely, an antibody reagent used for the detection of antigens for in vitro diagnostic use; diagnostic test kits comprised of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use; assays for research purposes; assay kits consisting primarily of assays, pre-mixes and onboard mixes for scientific, clinical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research purposes |
GS0011 | Diagnostic reagents and preparations for scientific, clinical laboratory, medical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research use; control and calibrating fluids and reagents for medical diagnostic instruments; control and calibrating fluids and reagents for laboratory instruments used for in vitro diagnostic testing and/or analysis; diagnostic reagents for scientific or medical research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; reagents for use in scientific apparatus for chemical or biological analysis; laboratory chemicals, namely, an antibody reagent used for the detection of antigens for in vitro diagnostic use; diagnostic test kits comprised of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use; assays for research purposes; assay kits consisting primarily of assays, pre-mixes and onboard mixes for scientific, clinical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-06-12 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-06-15 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-09-08 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-09-11 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-09-11 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-09-11 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-10-23 | 7 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-11-03 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-11-06 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-11-06 | 10 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2017-11-09 | 11 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2017-11-09 | 12 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-11-09 | 13 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2017-11-09 | 14 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-11-09 | 15 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-22 | 16 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-12-12 | 17 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-12-12 | 18 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-02-06 | 19 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-08-03 | 20 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-08-03 | 21 EXT1 S: |
EXTENSION 1 GRANTED | 2018-08-03 | 22 EX1G S: |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-08-03 | 23 TCCA I:Incoming Correspondence |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-08-07 | 24 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-02-05 | 25 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2019-02-05 | 26 EXT2 S: |
EXTENSION 2 GRANTED | 2019-02-05 | 27 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-02-07 | 28 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-08-05 | 29 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2019-08-05 | 30 EXT3 S: |
EXTENSION 3 GRANTED | 2019-08-05 | 31 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-07 | 32 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-02-05 | 33 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2020-02-05 | 34 EXT4 S: |
EXTENSION 4 GRANTED | 2020-02-05 | 35 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-02-07 | 36 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-08-05 | 37 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-08-18 | 38 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2020-08-05 | 39 EXT5 S: |
EXTENSION 5 GRANTED | 2020-08-18 | 40 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-19 | 41 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2021-01-28 | 42 EISU I:Incoming Correspondence |
USE AMENDMENT FILED | 2021-01-28 | 43 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2021-02-09 | 44 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-02-19 | 45 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-02-20 | 46 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2021-03-30 | 47 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.